Cargando…
Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma
In the last 2–3 decades, gene therapy represented a promising option for hepatocellular carcinoma (HCC) treatment. However, the design of safe and efficient gene delivery systems is still one of the major challenges that require solutions. In this study, we demonstrate a versatile method for covalen...
Autores principales: | Cao, Mingzhuo, Gao, Yong, Zhan, Mengling, Qiu, Nasha, Piao, Ying, Zhou, Zhuxian, Shen, Youqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829341/ https://www.ncbi.nlm.nih.gov/pubmed/31614879 http://dx.doi.org/10.3390/ijms20205074 |
Ejemplares similares
-
The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid
por: Graebin, Cedric Stephan
Publicado: (2017) -
Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?
por: Huang, Qing-Chun, et al.
Publicado: (2015) -
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
por: Liu, Jing, et al.
Publicado: (2021) -
Synthesis of glycyrrhetinic acid-modified liposomes to deliver Murrayafoline A for treatment of hepatocellular carcinoma
por: Dinh, Cuc Thi, et al.
Publicado: (2022) -
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
por: Zuo, Jiawei, et al.
Publicado: (2023)